Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer

Article ID	Journal	Published Year	Pages	File Type
5988420	The Journal of Thoracic and Cardiovascular Surgery	2016	14 Pages	PDF

Abstract

Postinduction PET avidity for N2 nodes is not associated with ypN2Â disease, overall survival, or disease-free survival in patients undergoing induction chemotherapy for stage IIIA/pN2 disease.

Keywords

Stage III NSCLC 10.2 CIR DFS SUVmax EBUS MSKCC Induction disease-free survival overall survival Port computed tomography Positron emission tomography Postoperative radiotherapy Non–small cell lung cancer NSCLC Endobronchial ultrasound Surgery Memorial Sloan Kettering Cancer Center PET

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Preview

Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer

Authors

R. Taylor MD, Kei MD, Kay See PhD, Prasad S. MD, James MD, Bernard J. MD, Robert J. MD, Nabil P. MD, MS, Valerie W. MD, Manjit MD, David R. MD,